NCT05738590

Brief Summary

Correlation between clinical , ultrasonographical, neurophysiological and histopathological findings in muscle diseases of different etiologies.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

February 22, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2024

Completed
Last Updated

February 22, 2023

Status Verified

February 1, 2023

Enrollment Period

1 year

First QC Date

January 24, 2023

Last Update Submit

February 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • microscopic picture of muscle in inflammatory and degenerative muscle disease

    true cut needle muscle biopsy is done to differentiate between inflammatory and degenerative muscle disease in microsopic picture

    1 year

Secondary Outcomes (2)

  • muscle ultrasound in inflammatory and degenerative muscle disease

    1 year

  • neurophysiology in inflammatory and degenerative muscle disease

    1 year

Study Arms (2)

inflammatory muscle disease

Procedure: muscle biopsy

degenerative muscle disease

Procedure: muscle biopsy

Interventions

muscle biopsyPROCEDURE

true cut needle biopsy

Also known as: neurophysiology(nerve conduction,electromyography), muscle ultrasound
degenerative muscle diseaseinflammatory muscle disease

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any patients with muscle disease of different etiologies aged from 18 years to 75 years, of both sex

You may qualify if:

  • Muscle diseases of different etiologies.
  • Any age.

You may not qualify if:

  • Patient refuse to participate.
  • The anatomy is altered due to severe trauma, tumor , or surgery.
  • Severe deformity preventing examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Myositis

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System Diseases

Central Study Contacts

Nageh Fouly kamal, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

January 24, 2023

First Posted

February 22, 2023

Study Start

April 1, 2023

Primary Completion

March 31, 2024

Study Completion

May 28, 2024

Last Updated

February 22, 2023

Record last verified: 2023-02